National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Erik Volz
2010 – 2013 Continue Reading Estimation of HIV Transmission Dynamics Using Genetic Sequences of Virus
Nascimento FF, Franceschi VB, Volz EM. (2026). treestructure: An R package to detect population structure in phylogenetic trees. Bioinformatics (Oxford, England)
Didelot X, Carson J, Ribeca P, Volz E. (2026). DiagnoDating: Diagnostics for dated phylogenies in microbial population genetics. Molecular biology and evolution
Volz E, Didelot X. (2026). Quantifying the predictability of evolution by analysis of coalescent rate variation. Molecular biology and evolution
Franceschi VB, Drake KO, Bibby DF, Sabin CA, Dunn DT, Mbisa JL, Volz EM. (2025). Evidence for circulation of high-virulence HIV-1 subtype B variants in the United Kingdom. Virus evolution, 11(1)
Nascimento FF, Mehta SR, Little SJ, Volz EM. (2025). Robust phylodynamic inference and model specification for HIV transmission dynamics. Epidemics, (52)
Broshkevitch CJ, Zhou S, Greifinger A, Enders K, Long N, Samoff E, Powers KA, Mobley V, Frost SDW, Volz E, Shone S, Eron JJ, Cohen MS, Swanstrom R, Dennis AM. (2025). Sequencing HIV Diagnostic Samples to Detect Genetic Clusters and Assess Sequence Coverage Gaps. Open forum infectious diseases, 12(6)
Chang S, Shin KS, Park B, Park S, Shin J, Park H, Jung IK, Kim JH, Bae SE, Kim JO, Baek SH, Kim G, Hong JJ, Seo H, Volz E, Kang CY. (2024). Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform. Proceedings of the National Academy of Sciences of the United States of America, 121(10)
Bonetti Franceschi V, Volz E. (2024). Phylogenetic signatures reveal multilevel selection and fitness costs in SARS-CoV-2. Wellcome open research, (9)
Kotokwe K, Nascimento FF, Moyo S, Gaseitsiwe S, Holme MP, Makhema J, Essex M, Novitsky V, Volz E, Ragonnet-Cronin M, . (2024). Phylodynamic Structure in the Botswana HIV Epidemic. Research square
Yu Q, Ascensao JA, Okada T, , Boyd O, Volz E, Hallatschek O. (2024). Lineage frequency time series reveal elevated levels of genetic drift in SARS-CoV-2 transmission in England. PLoS pathogens, 20(4)
Drake KO, Boyd O, Franceschi VB, Colquhoun RM, Ellaby NAF, Volz EM. (2024). Phylogenomic early warning signals for SARS-CoV-2 epidemic waves. EBioMedicine, (100)
Subissi L, Otieno JR, Worp N, Attar Cohen H, Oude Munnink BB, Abu-Raddad LJ, Alm E, Barakat A, Barclay WS, Bhiman JN, Caly L, Chand M, Chen M, Cullinane A, de Oliveira T, Drosten C, Druce J, Effler P, El Masry I, Faye A, Ghedin E, Grant R, Haagmans BL, Happi C, Herring BL, Hodcroft EB, Ikejezie J, Katawera V, Kassamali ZA, Leo YS, Leung GM, Kondor RJ, Marklewitz M, Mendez-Rico J, Melhem NM, Munster V, Nahapetyan K, Naindoo D, Oh DY, Peacock TP, Peiris M, Peng Z, Poon LLM, Rambaut A, Saha S, Shen Y, Siqueira MM, Volz E, Tessema SK, Thiel V, Triki H, van der Werf S, von Eije K, Cunningham J, Koopmans MPG, von Gottberg A, Agrawal A, Van Kerkhove MD. (2024). An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution. Nature medicine
Tsui JL, McCrone JT, Lambert B, Bajaj S, Inward RPD, Bosetti P, Pena RE, Tegally H, Hill V, Zarebski AE, Peacock TP, Liu L, Wu N, Davis M, Bogoch II, Khan K, Kall M, Abdul Aziz NIB, Colquhoun R, O'Toole Á, Jackson B, Dasgupta A, Wilkinson E, de Oliveira T, , Connor TR, Loman NJ, Colizza V, Fraser C, Volz E, Ji X, Gutierrez B, Chand M, Dellicour S, Cauchemez S, Raghwani J, Suchard MA, Lemey P, Rambaut A, Pybus OG, Kraemer MUG. (2023). Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1. Science (New York, N.Y.), 381(6655)
Nascimento FF, Mehta SR, Little SJ, Volz EM. (2023). Assessing transmission attribution risk from simulated sequencing data in HIV molecular epidemiology. AIDS (London, England)
Perez-Guzman PN, Knock E, Imai N, Rawson T, Elmaci Y, Alcada J, Whittles LK, Thekke Kanapram D, Sonabend R, Gaythorpe KAM, Hinsley W, FitzJohn RG, Volz E, Verity R, Ferguson NM, Cori A, Baguelin M. (2023). Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England. Nature communications, 14(1)
Volz E. (2023). Fitness, growth and transmissibility of SARS-CoV-2 genetic variants. Nature reviews. Genetics
Perez-Guzman PN, Knock E, Imai N, Rawson T, Elmaci Y, Alcada J, Whittles LK, Thekke Kanapram D, Sonabend R, Gaythorpe KAM, Hinsley W, FitzJohn RG, Volz E, Verity R, Ferguson NM, Cori A, Baguelin M. (2023). Author Correction: Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England. Nature communications, 14(1)
Didelot X, Franceschi V, Frost SDW, Dennis A, Volz EM. (2023). Model design for nonparametric phylodynamic inference and applications to pathogen surveillance. Virus evolution, 9(1)
Eales O, Page AJ, Tang SN, Walters CE, Wang H, Haw D, Trotter AJ, Le Viet T, Foster-Nyarko E, Prosolek S, Atchison C, Ashby D, Cooke G, Barclay W, Donnelly CA, O'Grady J, Volz E, The Covid-Genomics Uk Cog-Uk Consortium, Darzi A, Ward H, Elliott P, Riley S. (2023). The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021. Microbial genomics, 9(2)
Subissi L, von Gottberg A, Thukral L, Worp N, Oude Munnink BB, Rathore S, Abu-Raddad LJ, Aguilera X, Alm E, Archer BN, Attar Cohen H, Barakat A, Barclay WS, Bhiman JN, Caly L, Chand M, Chen M, Cullinane A, de Oliveira T, Drosten C, Druce J, Effler P, El Masry I, Faye A, Gaseitsiwe S, Ghedin E, Grant R, Haagmans BL, Herring BL, Iyer SS, Kassamali Z, Kakkar M, Kondor RJ, Leite JA, Leo YS, Leung GM, Marklewitz M, Moyo S, Mendez-Rico J, Melhem NM, Munster V, Nahapetyan K, Oh DY, Pavlin BI, Peacock TP, Peiris M, Peng Z, Poon LLM, Rambaut A, Sacks J, Shen Y, Siqueira MM, Tessema SK, Volz EM, Thiel V, van der Werf S, Briand S, Perkins MD, Van Kerkhove MD, Koopmans MPG, Agrawal A. (2022). An early warning system for emerging SARS-CoV-2 variants. Nature medicine
Stirrup O, Tostevin A, Ragonnet-Cronin M, Volz E, Burns F, Delpech V, Dunn D. (2022). Diagnosis delays in the UK according to pre or postmigration acquisition of HIV. AIDS (London, England), 36(3)
Hill V, Du Plessis L, Peacock TP, Aggarwal D, Colquhoun R, Carabelli AM, Ellaby N, Gallagher E, Groves N, Jackson B, McCrone JT, O'Toole Á, Price A, Sanderson T, Scher E, Southgate J, Volz E, Barclay WS, Barrett JC, Chand M, Connor T, Goodfellow I, Gupta RK, Harrison EM, Loman N, Myers R, Robertson DL, Pybus OG, Rambaut A. (2022). The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK. Virus evolution, 8(2)
Aggarwal D, Page AJ, Schaefer U, Savva GM, Myers R, Volz E, Ellaby N, Platt S, Groves N, Gallagher E, Tumelty NM, Le Viet T, Hughes GJ, Chen C, Turner C, Logan S, Harrison A, , Peacock SJ, Chand M, Harrison EM. (2022). Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission. Nature communications, 13(1)
Nascimento FF, Ragonnet-Cronin M, Golubchik T, Danaviah S, Derache A, Fraser C, Volz E. (2022). Evaluating whole HIV-1 genome sequence for estimation of incidence and migration in a rural South African community. Wellcome open research, (7)
Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, Hinsley W, Bernal JL, Kall M, Bhatt S, Blomquist P, Zaidi A, Volz E, Aziz NA, Harman K, Funk S, Abbott S, , Hope R, Charlett A, Chand M, Ghani AC, Seaman SR, Dabrera G, De Angelis D, Presanis AM, Thelwall S. (2022). Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet
McCrone JT, Hill V, Bajaj S, Pena RE, Lambert BC, Inward R, Bhatt S, Volz E, Ruis C, Dellicour S, Baele G, Zarebski AE, Sadilek A, Wu N, Schneider A, Ji X, Raghwani J, Jackson B, Colquhoun R, O'Toole Á, Peacock TP, Twohig K, Thelwall S, Dabrera G, Myers R, , Faria NR, Huber C, Bogoch II, Khan K, du Plessis L, Barrett JC, Aanensen DM, Barclay WS, Chand M, Connor T, Loman NJ, Suchard MA, Pybus OG, Rambaut A, Kraemer MUG. (2022). Context-specific emergence and growth of the SARS-CoV-2 Delta variant. Nature
Vöhringer HS, Sanderson T, Sinnott M, De Maio N, Nguyen T, Goater R, Schwach F, Harrison I, Hellewell J, Ariani CV, Gonçalves S, Jackson DK, Johnston I, Jung AW, Saint C, Sillitoe J, Suciu M, Goldman N, Panovska-Griffiths J, , , Birney E, Volz E, Funk S, Kwiatkowski D, Chand M, Martincorena I, Barrett JC, Gerstung M. (2022). Publisher Correction: Genomic reconstruction of the SARS CoV-2 epidemic in England. Nature
Sonabend R, Whittles LK, Imai N, Perez-Guzman PN, Knock ES, Rawson T, Gaythorpe KAM, Djaafara BA, Hinsley W, FitzJohn RG, Lees JA, Kanapram DT, Volz EM, Ghani AC, Ferguson NM, Baguelin M, Cori A. (2021). Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study. Lancet, 398(10313)
Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, Hinsley WR, Laydon DJ, Dabrera G, O'Toole Á, Amato R, Ragonnet-Cronin M, Harrison I, Jackson B, Ariani CV, Boyd O, Loman NJ, McCrone JT, Gonçalves S, Jorgensen D, Myers R, Hill V, Jackson DK, Gaythorpe K, Groves N, Sillitoe J, Kwiatkowski DP, , Flaxman S, Ratmann O, Bhatt S, Hopkins S, Gandy A, Rambaut A, Ferguson NM. (2021). Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature
Kraemer MUG, Hill V, Ruis C, Dellicour S, Bajaj S, McCrone JT, Baele G, Parag KV, Battle AL, Gutierrez B, Jackson B, Colquhoun R, O'Toole Á, Klein B, Vespignani A, , Volz E, Faria NR, Aanensen D, Loman NJ, du Plessis L, Cauchemez S, Rambaut A, Scarpino SV, Pybus OG. (2021). Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science (New York, N.Y.)
Li X, Liu H, Rife Magalis B, Kosakovsky Pond SL, Volz EM. (2021). Molecular Evolution of Human Norovirus GII.2 Clusters. Frontiers in microbiology, (12)
Mishra S, Mindermann S, Sharma M, Whittaker C, Mellan TA, Wilton T, Klapsa D, Mate R, Fritzsche M, Zambon M, Ahuja J, Howes A, Miscouridou X, Nason GP, Ratmann O, Semenova E, Leech G, Sandkühler JF, Rogers-Smith C, Vollmer M, Unwin HJT, Gal Y, Chand M, Gandy A, Martin J, Volz E, Ferguson NM, Bhatt S, Brauner JM, Flaxman S, . (2021). Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England. EClinicalMedicine, (39)
Nouvellet P, Bhatia S, Cori A, Ainslie KEC, Baguelin M, Bhatt S, Boonyasiri A, Brazeau NF, Cattarino L, Cooper LV, Coupland H, Cucunuba ZM, Cuomo-Dannenburg G, Dighe A, Djaafara BA, Dorigatti I, Eales OD, van Elsland SL, Nascimento FF, FitzJohn RG, Gaythorpe KAM, Geidelberg L, Green WD, Hamlet A, Hauck K, Hinsley W, Imai N, Jeffrey B, Knock E, Laydon DJ, Lees JA, Mangal T, Mellan TA, Nedjati-Gilani G, Parag KV, Pons-Salort M, Ragonnet-Cronin M, Riley S, Unwin HJT, Verity R, Vollmer MAC, Volz E, Walker PGT, Walters CE, Wang H, Watson OJ, Whittaker C, Whittles LK, Xi X, Ferguson NM, Donnelly CA. (2021). Reduction in mobility and COVID-19 transmission. Nature communications, 12(1)
Didelot X, Geidelberg L, , Volz EM. (2021). Model design for non-parametric phylodynamic inference and applications to pathogen surveillance. bioRxiv : the preprint server for biology
Vöhringer HS, Sanderson T, Sinnott M, De Maio N, Nguyen T, Goater R, Schwach F, Harrison I, Hellewell J, Ariani CV, Gonçalves S, Jackson DK, Johnston I, Jung AW, Saint C, Sillitoe J, Suciu M, Goldman N, Panovska-Griffiths J, , , Birney E, Volz E, Funk S, Kwiatkowski D, Chand M, Martincorena I, Barrett JC, Gerstung M. (2021). Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature
Bhatia S, Imai N, Cuomo-Dannenburg G, Baguelin M, Boonyasiri A, Cori A, Cucunubá Z, Dorigatti I, FitzJohn R, Fu H, Gaythorpe K, Ghani A, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Okell L, Riley S, Thompson H, van Elsland S, Volz E, Wang H, Wang Y, Whittaker C, Xi X, Donnelly CA, Ferguson NM. (2021). Estimating the number of undetected COVID-19 cases among travellers from mainland China. Wellcome open research, (5)
Ragonnet-Cronin M, Boyd O, Geidelberg L, Jorgensen D, Nascimento FF, Siveroni I, Johnson RA, Baguelin M, Cucunubá ZM, Jauneikaite E, Mishra S, Watson OJ, Ferguson N, Cori A, Donnelly CA, Volz E. (2021). Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions. Nature communications, 12(1)
du Plessis L, McCrone JT, Zarebski AE, Hill V, Ruis C, Gutierrez B, Raghwani J, Ashworth J, Colquhoun R, Connor TR, Faria NR, Jackson B, Loman NJ, O'Toole Á, Nicholls SM, Parag KV, Scher E, Vasylyeva TI, Volz EM, Watts A, Bogoch II, Khan K, , Aanensen DM, Kraemer MUG, Rambaut A, Pybus OG. (2021). Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science (New York, N.Y.)
Helekal D, Ledda A, Volz E, Wyllie D, Didelot X. (2021). Bayesian inference of clonal expansions in a dated phylogeny. Systematic biology
Dennis AM, Frost SDW, Enders K, Cressman AE, Volz E, Adams N, Miller WC, Cohen MS, Mobley V, Samoff E, Eron JJ. (2021). HIV-1 Transmission linkages among persons with incident infection to inform public health surveillance. EClinicalMedicine, (37)
Ragonnet-Cronin M, Golubchik T, Moyo S, Fraser C, Essex M, Novitsky V, Volz E,. (2021). HIV genetic diversity informs stage of HIV-1 infection among patients receiving antiretroviral therapy in Botswana. The Journal of infectious diseases
Geidelberg L, Boyd O, Jorgensen D, Siveroni I, Nascimento FF, Johnson R, Ragonnet-Cronin M, Fu H, Wang H, Xi X, Chen W, Liu D, Chen Y, Tian M, Tan W, Zai J, Sun W, Li J, Li J, Volz EM, Li X, Nie Q. (2020). Genomic epidemiology of a densely sampled COVID-19 outbreak in China. Virus evolution, 7(1)
Okell LC, Verity R, Katzourakis A, Volz EM, Watson OJ, Mishra S, Walker P, Whittaker C, Donnelly CA, Riley S, Ghani AC, Gandy A, Flaxman S, Ferguson NM, Bhatt S. (2020). Host or pathogen-related factors in COVID-19 severity? - Authors' reply. Lancet, 396(10260)
Fountain-Jones NM, Appaw RC, Carver S, Didelot X, Volz E, Charleston M. (2020). Emerging phylogenetic structure of the SARS-CoV-2 pandemic. Virus evolution, 6(2)
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunubá Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM. (2020). Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet. Infectious diseases
Didelot X, Siveroni I, Volz EM. (2020). Additive uncorrelated relaxed clock models for the dating of genomic epidemiology phylogenies. Molecular biology and evolution
Maurano MT, Ramaswami S, Zappile P, Dimartino D, Boytard L, Ribeiro-Dos-Santos AM, Vulpescu NA, Westby G, Shen G, Feng X, Hogan MS, Ragonnet-Cronin M, Geidelberg L, Marier C, Meyn P, Zhang Y, Cadley J, Ordoñez R, Luther R, Huang E, Guzman E, Arguelles-Grande C, Argyropoulos KV, Black M, Serrano A, Call ME, Kim MJ, Belovarac B, Gindin T, Lytle A, Pinnell J, Vougiouklakis T, Chen J, Lin LH, Rapkiewicz A, Raabe V, Samanovic MI, Jour G, Osman I, Aguero-Rosenfeld M, Mulligan MJ, Volz EM, Cotzia P, Snuderl M, Heguy A. (2020). Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region. Genome research, 30(12)
Thompson HA, Imai N, Dighe A, Ainslie KEC, Baguelin M, Bhatia S, Bhatt S, Boonyasiri A, Boyd O, Brazeau NF, Cattarino L, Cooper LV, Coupland H, Cucunuba Z, Cuomo-Dannenburg G, Djaafara B, Dorigatti I, Elsland S, FitzJohn R, Fu H, Gaythorpe KAM, Green W, Hallett T, Hamlet A, Haw D, Hayes S, Hinsley W, Jeffrey B, Knock E, Laydon DJ, Lees J, Mangal TD, Mellan T, Mishra S, Mousa A, Nedjati-Gilani G, Nouvellet P, Okell L, Parag KV, Ragonnet-Cronin M, Riley S, Unwin HJT, Verity R, Vollmer M, Volz E, Walker PGT, Walters C, Wang H, Wang Y, Watson OJ, Whittaker C, Whittles LK, Winskill P, Xi X, Donnelly CA, Ferguson NM. (2020). SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China. Journal of travel medicine
Maurano MT, Ramaswami S, Zappile P, Dimartino D, Boytard L, Ribeiro-Dos-Santos AM, Vulpescu NA, Westby G, Shen G, Feng X, Hogan MS, Ragonnet-Cronin M, Geidelberg L, Marier C, Meyn P, Zhang Y, Cadley J, Ordoñez R, Luther R, Huang E, Guzman E, Arguelles-Grande C, Argyropoulos KV, Black M, Serrano A, Call ME, Kim MJ, Belovarac B, Gindin T, Lytle A, Pinnell J, Vougiouklakis T, Chen J, Lin LH, Rapkiewicz A, Raabe V, Samanovic MI, Jour G, Osman I, Aguero-Rosenfeld M, Mulligan MJ, Volz EM, Cotzia P, Snuderl M, Heguy A. (2020). Sequencing identifies multiple, early introductions of SARS-CoV2 to New York City Region. medRxiv : the preprint server for health sciences
Volz EM, Wiuf C, Grad YH, Frost SDW, Dennis AM, Didelot X. (2020). Identification of hidden population structure in time-scaled phylogenies. Systematic biology
Poletto C, Scarpino SV, Volz EM. (2020). Applications of predictive modelling early in the COVID-19 epidemic. The Lancet. Digital health
Volz E, Hill V, McCrone JT, Price A, Jorgensen D, O'Toole Á, Southgate J, Johnson R, Jackson B, Nascimento FF, Rey SM, Nicholls SM, Colquhoun RM, da Silva Filipe A, Shepherd J, Pascall DJ, Shah R, Jesudason N, Li K, Jarrett R, Pacchiarini N, Bull M, Geidelberg L, Siveroni I, , Goodfellow I, Loman NJ, Pybus OG, Robertson DL, Thomson EC, Rambaut A, Connor TR. (2021). Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity. Cell, 184(1)
Fu H, Wang H, Xi X, Boonyasiri A, Wang Y, Hinsley W, Fraser KJ, McCabe R, Olivera Mesa D, Skarp J, Ledda A, Dewé T, Dighe A, Winskill P, van Elsland SL, Ainslie KEC, Baguelin M, Bhatt S, Boyd O, Brazeau NF, Cattarino L, Charles G, Coupland H, Cucunuba ZM, Cuomo-Dannenburg G, Donnelly CA, Dorigatti I, Eales OD, FitzJohn RG, Flaxman S, Gaythorpe KAM, Ghani AC, Green WD, Hamlet A, Hauck K, Haw DJ, Jeffrey B, Laydon DJ, Lees JA, Mellan T, Mishra S, Nedjati-Gilani G, Nouvellet P, Okell L, Parag KV, Ragonnet-Cronin M, Riley S, Schmit N, Thompson HA, Unwin HJT, Verity R, Vollmer MAC, Volz E, Walker PGT, Walters CE, Watson OJ, Whittaker C, Whittles LK, Imai N, Bhatia S, Ferguson NM. (2020). Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (102)
Nascimento FF, Baral S, Geidelberg L, Mukandavire C, Schwartz SR, Turpin G, Turpin N, Diouf D, Diouf NL, Coly K, Kane CT, Ndour C, Vickerman P, Boily MC, Volz EM. (2020). Phylodynamic analysis of HIV-1 subtypes B, C and CRF 02_AG in Senegal. Epidemics, (30)
Le Vu S, Ratmann O, Delpech V, Brown AE, Gill ON, Tostevin A, Dunn D, Fraser C, Volz EM. (2019). HIV-1 Transmission Patterns in Men Who Have Sex with Men: Insights from Genetic Source Attribution Analysis. AIDS research and human retroviruses, 35(9)
Volz EM, Siveroni I. (2018). Bayesian phylodynamic inference with complex models. PLoS computational biology, 14(11)
Volz EM, Didelot X. (2018). Modeling the Growth and Decline of Pathogen Effective Population Size Provides Insight into Epidemic Dynamics and Drivers of Antimicrobial Resistance. Systematic biology, 67(4)
Volz EM, Ndembi N, Nowak R, Kijak GH, Idoko J, Dakum P, Royal W, Baral S, Dybul M, Blattner WA, Charurat M. (2017). Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics. Virus evolution, 3(2)
Volz EM, Romero-Severson E, Leitner T. (2017). Phylodynamic Inference across Epidemic Scales. Molecular biology and evolution, 34(5)
Le Vu S, Ratmann O, Delpech V, Brown AE, Gill ON, Tostevin A, Fraser C, Volz EM. (2018). Comparison of cluster-based and source-attribution methods for estimating transmission risk using large HIV sequence databases. Epidemics, (23)
Ratmann O, Hodcroft EB, Pickles M, Cori A, Hall M, Lycett S, Colijn C, Dearlove B, Didelot X, Frost S, Hossain AS, Joy JB, Kendall M, Kühnert D, Leventhal GE, Liang R, Plazzotta G, Poon AF, Rasmussen DA, Stadler T, Volz E, Weis C, Leigh Brown AJ, Fraser C, . (2016). Phylogenetic Tools for Generalized HIV-1 Epidemics: Findings from the PANGEA-HIV Methods Comparison. Molecular biology and evolution, 34(1)
Sadasivam RS, Cutrona SL, Luger TM, Volz E, Kinney R, Rao SR, Allison JJ, Houston TK. (2017). Share2Quit: Online Social Network Peer Marketing of Tobacco Cessation Systems. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 19(3)
Volz EM, Frost SD. (2014). Sampling through time and phylodynamic inference with coalescent and birth-death models. Journal of the Royal Society, Interface, 11(101)
Alam SJ, Zhang X, Romero-Severson EO, Henry C, Zhong L, Volz EM, Brenner BG, Koopman JS. (2013). Detectable signals of episodic risk effects on acute HIV transmission: strategies for analyzing transmission systems using genetic data. Epidemics, 5(1)
Sadasivam RS, Volz EM, Kinney RL, Rao SR, Houston TK. (2013). Share2Quit: Web-Based Peer-Driven Referrals for Smoking Cessation. JMIR research protocols, 2(2)
Frost SD, Volz EM. (2013). Modelling tree shape and structure in viral phylodynamics. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 368(1614)
Zhang X, Zhong L, Romero-Severson E, Alam SJ, Henry CJ, Volz EM, Koopman JS. (2012). Episodic HIV Risk Behavior Can Greatly Amplify HIV Prevalence and the Fraction of Transmissions from Acute HIV Infection. Statistical communications in infectious diseases, 4(1)
Miller JC, Volz EM. (2013). Model hierarchies in edge-based compartmental modeling for infectious disease spread. Journal of mathematical biology, 67(4)
Romero-Severson EO, Alam SJ, Volz EM, Koopman JS. (2012). Heterogeneity in Number and Type of Sexual Contacts in a Gay Urban Cohort. Statistical communications in infectious diseases, 4(1)
Miller JC, Slim AC, Volz EM. (2012). Edge-based compartmental modelling for infectious disease spread. Journal of the Royal Society, Interface, 9(70)
Volz EM. (2011). Complex population dynamics and the coalescent under neutrality. Genetics, 190(1)
Frost SD, Volz EM. (2010). Viral phylodynamics and the search for an 'effective number of infections'. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 365(1548)
Abramovitz D, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost SD, . (2009). Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit?. Sexually transmitted diseases, 36(12)
Volz EM, Kosakovsky Pond SL, Ward MJ, Leigh Brown AJ, Frost SD. (2009). Phylodynamics of infectious disease epidemics. Genetics, 183(4)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.